The nation’s drive to prevent outbreaks of severe enterovirus will see a breakthrough in September with the start of human clinical trials of a locally developed vaccine against the deadliest type of the virus, EV71, National Cheng Kung University Hospital deputy superintendent Su Ih-jen (蘇益仁) said.
Su, who also headed an EV71 vaccine research team under the National Health Research Institute (NHRI), said his team has overcome a production bottleneck and will be able to release an EV71 vaccine commercially in four months.
Su said the vaccine was developed with EV71-B4 subtype samples provided by the NHRI that were produced into a “seed stock” to form the basis for the vaccine.
The first phase of the clinical trial is scheduled to be launched in September after the Department of Health (DOH) approves the program, Su said, adding that they will be carried out at National Taiwan University Hospital (NTUH) and Taipei Veterans General Hospital, with 30 adults as the trial subjects.
“The main purpose of this stage of the trial is to assess the vaccine’s safety and possible side effects,” Su said, adding that the second and third phases of the trial will focus on observing the vaccine’s efficacy in children.
Once the vaccine passes the human trials, Su said, production can begin in four months, if necessary.
“In other words, the vaccine can be available for an immunization program in January 2011, at the earliest,” Su said.
As EV71 has various strands of viruses prevailing in different areas at different times, Su went on, mass production couldn’t begin until after the vaccine’s specification has been determined.
Citing Centers for Disease Control statistics, Su said the number of cases of EV71 infection accounted for only about 20 percent of the total number of severe enterovirus cases reported between 2000 and 2008.
The figure indicates that children will still have a 70 percent to 80 percent chance of contracting other types of severe enterovirus, Su said.
Given this, he asked how the DOH could convince local parents to get their children vaccinated.
In recent years, Su said, the strands of the EV71 virus prevalent in Taiwan have been B5 and C4, while those commonly seen in other Asian countries are C5 in China, C1, C4 and C5 in Vietnam and B5 in Malaysia.
To meet the demand of local children aged under 3, Taiwan would need to produce 600,000 doses of vaccine, a number Su said is not enough to generate an economy of scale.
Noting that China is also developing an EV71 vaccine, Su said Taiwan should try to use the APEC forum as a platform to develop a vaccine that can be effectively used in enterovirus immunization throughout Asia.
“That way, we could produce up to 20 million doses for sale across Asia to realize an economy of scale,” he said.
Huang Li-min (黃立民), director of NTUH’s pediatric infectious diseases division, added that as there are over 100 strands of the enterovirus, it will not be easy to produce a vaccine capable of preventing all those types of the infection.
Enterovirus vaccines are brand new, he added.
“It would be better to develop a vaccine on the basis of samples of a single type of virus. The issue regarding cross-protection for the various subtypes should be considered at a later stage,” he said.
For the locally developed EV71 vaccine, Huang said, NTUH would not launch a third stage of clinical trials among 5,000 to 10,000 children unless the first and second stages of testing are successful.
“It will also be a challenge to persuade local parents to enroll their children in the trial,” he added.
Aftershocks from a magnitude 6.2 earthquake that struck off Yilan County at 3:45pm yesterday could reach a magnitude of 5 to 5.5, the Central Weather Administration (CWA) said. Seismological Center technical officer Chiu Chun-ta (邱俊達) told a news conference that the epicenter of the temblor was more than 100km from Taiwan. Although predicted to measure between magnitude 5 and 5.5, the aftershocks would reach an intensity of 1 on Taiwan’s 7-tier scale, which gauges the actual effect of an earthquake, he said. The earthquake lasted longer in Taipei because the city is in a basin, he said. The quake’s epicenter was about 128.9km east-southeast
The Taipei Summer Festival is to begin tomorrow at Dadaocheng Wharf (大稻埕), featuring four themed firework shows and five live music performances throughout the month, the Taipei Department of Information and Tourism said today. The festival in the city’s Datong District (大同) is to run until Aug. 30, holding firework displays on Wednesdays and the final Saturday of the event. The first show is scheduled for tomorrow, followed by Aug. 13, 20 and 30. To celebrate the 30th anniversary of Disney Pixar's movie Toy Story, the festival has partnered with Walt Disney Co (Taiwan) to host a special themed area on
BE CAREFUL: The virus rarely causes severe illness or death, but newborns, older people and those with medical conditions are at risk of more severe illness As more than 7,000 cases of chikungunya fever have been reported in China’s Guangdong Province this year, including 2,892 new cases last week, the Centers for Disease Control (CDC) yesterday said it is monitoring the situation and considering raising the travel notice level, which might be announced today. The CDC issued a level 1 travel notice, or “watch,” for Guangdong Province on July 22, citing an outbreak in Foshan, a manufacturing hub in the south of the province, that was reported early last month. Between July 27 and Saturday, the province reported 2,892 new cases of chikungunya, reaching a total of 7,716
STAY VIGILANT: People should reduce the risk of chronic liver inflammation by avoiding excessive alcohol consumption, smoking and eating pickled foods, the physician said A doctor last week urged people to look for five key warning signs of acute liver failure after popular producer-turned-entertainer Shen Yu-lin (沈玉琳) was reportedly admitted to an intensive care unit for fulminant hepatitis. Fulminant hepatitis is the rapid and massive death of liver cells, impairing the organ’s detoxification, metabolic, protein synthesis and bile production functions, which if left untreated has a mortality rate as high as 80 percent, according to the Web site of Advancing Clinical Treatment of Liver Disease, an international organization focused on liver disease prevention and treatment. People with hepatitis B or C are at higher risk of
RSS